DexCom

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade DexCom 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DXCM

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. 

CEO
Jacob S. Leach
CEOJacob S. Leach
Employees
11,100
Employees11,100
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1999
Founded1999
Employees
11,100
Employees11,100

DXCM Key Statistics

Market cap
32.20B
Market cap32.20B
Price-Earnings ratio
32.14
Price-Earnings ratio32.14
Dividend yield
Dividend yield
Average volume
5.02M
Average volume5.02M
High today
$84.70
High today$84.70
Low today
$78.74
Low today$78.74
Open price
$79.88
Open price$79.88
Volume
11.98M
Volume11.98M
52 Week high
$84.70
52 Week high$84.70
52 Week low
$54.11
52 Week low$54.11

Stock Snapshot

DexCom(DXCM) stock is priced at $83.05, giving the company a market capitalization of 32.2B. It carries a P/E multiple of 32.14.

During the trading session on 2026-08-01, DexCom(DXCM) shares reached a daily high of $84.70 and a low of $78.74. At a current price of $83.05, the stock is +5.5% higher than the low and still -1.9% under the high.

Trading volume for DexCom(DXCM) stock has reached 11.98M, versus its average volume of 5.02M.

The stock's 52-week range extends from a low of $54.11 to a high of $84.70.

The stock's 52-week range extends from a low of $54.11 to a high of $84.70.

DXCM News

Simply Wall St 12h
DexCom Stock Surges On Margin Strength And Raised Outlook

DexCom stock rose 12% to US$83.45 after earnings, a sharp move for a large medical device company that has already delivered strong multi month gains. The headl...

DexCom Stock Surges On Margin Strength And Raised Outlook
Simply Wall St 21h
DexCom Stock May Be Below Fair Value Following Raised Guidance

DexCom stock has delivered a roughly 43.1% decline over the past five years, yet an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach curr...

DexCom Stock May Be Below Fair Value Following Raised Guidance
Nasdaq 22h
DexCom Stock Up on Q2 Earnings & Revenue Beat, Margins Rise

DexCom, Inc. DXCM reported second-quarter 2026 adjusted earnings per share (EPS) of 70 cents, which beat the Zacks Consensus Estimate of 61 cents by 14.8%. The...

DexCom Stock Up on Q2 Earnings & Revenue Beat, Margins Rise

Analyst ratings

84%

of 31 ratings
Buy
83.9%
Hold
16.1%
Sell
0%

More DXCM News

TipRanks 1d
DexCom price target raised to $92 from $86 at Deutsche Bank

Deutsche Bank analyst Kieran Ryan raised the firm’s price target on DexCom (DXCM) to $92 from $86 and keeps a Buy rating on the shares. Unlock powerful investi...

TipRanks 1d
Dexcom: Broad-Based Revenue Beat and Margin Strength Underpin Josh Jennings’ Buy Rating

Dexcom, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Josh Jennings from TD Cowen reiterated a Buy rating on the stoc...

The Motley Fool 2d
DexCom Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. Thursday, July 30, 2026 at 4:30 p.m. ET CALL PARTICIPANTS senior vice president of finance and investor relations - Sean Christen...

DexCom Q2 2026 Earnings Call Transcript
Nasdaq 2d
DexCom Inc. Reveals Advance In Q2 Income

(RTTNews) - DexCom Inc. (DXCM) reported a profit for its second quarter that Increases, from last year The company's earnings totaled $249.1 million, or $0.64...

DexCom Inc. Reveals Advance In Q2 Income
Simply Wall St 5d
DexCom Wins Health Canada Approval, Is The Stock Trading At A Discount?

DexCom (DXCM) is back in focus after Health Canada authorized the Dexcom G7 15 Day continuous glucose monitoring system, extending approved sensor wear to 15.5...

DexCom Wins Health Canada Approval, Is The Stock Trading At A Discount?

People also own

Based on the portfolios of people who own DXCM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.